Innovative Products Xeltis is developing artificial vessels and valves that are gradually replaced by patients' own living healthy tissue. This revolutionary technology positions Xeltis as a leader in transformative implants, providing a unique selling point for medical professionals seeking innovative solutions.

Recognized Excellence Xeltis has received prestigious accolades like the Breakthrough Device Designation, enhancing its credibility in the medical equipment manufacturing industry. Leveraging these recognitions in sales pitches can help establish Xeltis as a trusted and proven provider of cutting-edge medical implants.

Strategic Hires Recent key appointments of experienced professionals like Rob Eyers as CTO, Luc Verhees as Vice President of Clinical Business Development, and Shawn Gage as Vice President of US Clinical Affairs demonstrate Xeltis' commitment to growth and expertise. Utilizing the expertise of these leaders can help forge valuable partnerships and drive sales growth.

Strong Financial Backing With significant funding rounds and investments from reputable sources such as the European Commission, Xeltis boasts financial stability and growth potential. This financial backing enhances Xeltis' credibility and reliability, instilling confidence in potential clients and partners.

Market Visibility Xeltis' participation in prominent events like VEITHsymposium 2023 and coverage in industry publications increases its market visibility and reputation. Leveraging these opportunities to showcase the company's achievements and advancements can attract new clients and foster industry partnerships.